Early recognition and treatment of rheumatoid arthritis is the key to a more successful outcome. This article discusses the diagnosis of rheumatoid arthritis and its recommended management.
Prescriber Template
Write in a clean editor, then format for Prescriber in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Prescriber format
Prescriber is a peer-reviewed journal published by Wiley, covering Pharmaceutical Practices and Patient Outcomes, Pharmaceutical studies and practices, Health Systems, Economic Evaluations, Quality of Life.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Prescriber 12 (3): 45–58.
Formats any DOI in Prescriber style. No sign-up. |
| Publishes research in | Pharmaceutical Practices and Patient Outcomes Pharmaceutical studies and practices Health Systems, Economic Evaluations, Quality of Life Pharmaceutical Economics and Policy Nursing Roles and Practices |
| ISSN | 0959-6682 |
| Citation impact (2-yr) | 0.41 |
| h-index | 21 |
| i10-index | 64 |
| Total citations | 4,354 |
| Top institutions publishing here | John Wiley & Sons (United Kingdom) |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Prescriber per year
Citation impact of Prescriber by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Prescriber
To compare the adverse effects of therapy with tumour necrosis factor blocker -etanercept (Enbrel), adalimumab (Humira), infliximab (Remicade), golimumab (Simponi) and certolizumab (Cimzia) -interleukin (IL)-1 antagonist -anakinra (Kineret) -IL-6 antagonist -tocilizumab (RoActemra) -anti
A Cochrane analysis compared efficacy and side effects of mirtazapine with other antidepressants. After six weeks of treatment no reliable difference of efficacy between mirtazapine, selective serotonin reuptake inhibitors (SSRI), noradrenaline reuptake inhibitors or tricyclic antidepressants was found. The side effects like increased sleep and weight gain were compared by treatment with mirtazapine and treatment…
NICE published a new guideline in September 2018 on the diagnosis and management of chronic heart failure in adults (NG106). This article provides a summary of the guideline and how it differs from previous NICE guidance and the 2016 SIGN guidance.